Skin bacterial richness and diversity in intensive care unit patients with severe pneumoniaOriginal paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
This study asked how the skin microbiota of intensive care unit patients with severe pneumonia differs from that of healthy people. The skin community may influence the risk of healthcare-associated infection. Researchers used 16S ribosomal RNA gene sequencing to measure skin bacterial richness and diversity. Data were analysed with the QIIME bioinformatics pipeline. To test whether skin bacteria overlapped with airway pathogens, they also cultured blood, endotracheal aspirate, and bronchoalveolar lavage fluid from the same patients.
Who was studied?
The study compared an intensive care patient group with severe pneumonia to a healthy control group. Patients were admitted to the intensive care unit and faced high mortality risk. The work was based on human skin swabs analysed by 16S sequencing. Paired blood and respiratory samples were taken from the same patient group for culture. Exact group sizes and demographic details were not stated.
What were the most important findings?
Compared with healthy controls, skin bacterial diversity in the patient group decreased significantly. This loss of diversity marked the critically ill patients. Several genera were differentially abundant on patient skin, including Staphylococcus, Acinetobacter, Stenotrophomonas, Enterococcus, Halomonas, and Brevibacillus. Most of these same bacteria were also identified in cultures of upper respiratory tract samples from the same patients, linking skin flora to airway isolates.
What are the greatest implications of this study?
The overlap between skin genera and cultured airway pathogens suggests skin may be a reservoir contributing to healthcare-associated infection. This points to skin as a target for infection control. The authors argue that preventing and controlling skin bacterial pathogens could matter for intensive care patients with severe pneumonia. Because the design is observational and cross-sectional, it shows association rather than proof that skin bacteria cause the airway infections.